Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
54
BLTE Quote, Financials, Valuation and Earnings
Last price:
$154.94
Seasonality move
:
-4.96%
Day range:
$148.10 - $157.48
52-week range:
$49.00 - $170.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
21.23x
Volume:
159.5K
Avg. volume:
250.9K
1-year change:
192.44%
Market cap:
$5.8B
Revenue:
--
EPS (TTM):
-$1.92
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $17K | $30K | $198K | $399K | $449K | |
| Gross Profit | -$17K | -$30K | -$198K | -$399K | -$449K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3.7M | $7.4M | $8.9M | $24.8M | $29.9M | |
| Selling, General & Admin | $2.1M | $2.4M | $4M | $6.8M | $10.1M | |
| Other Inc / (Exp) | -- | $126K | $166K | -$4K | $141K | |
| Operating Expenses | $5.7M | $9.8M | $12.6M | $31.3M | $39.5M | |
| Operating Income | -$5.7M | -$9.8M | -$12.8M | -$31.7M | -$40M | |
| Net Interest Expenses | $21K | -- | $16K | $25K | $20K | |
| EBT. Incl. Unusual Items | -$5.8M | -$9.7M | -$12.6M | -$31.6M | -$36.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1K | -- | -- | $9K | $6K | |
| Net Income to Company | -$5.8M | -$9.7M | -$12.6M | -$31.6M | -$36.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$5.8M | -$9.7M | -$12.6M | -$31.6M | -$36.1M | |
| Basic EPS (Cont. Ops) | -$0.00 | -$0.40 | -$0.63 | -$1.19 | -$1.18 | |
| Diluted EPS (Cont. Ops) | -$0.00 | -$0.40 | -$0.63 | -$1.19 | -$1.18 | |
| Weighted Average Basic Share | $24.1M | $24.1M | $20M | $26.6M | $30.5M | |
| Weighted Average Diluted Share | $24.1M | $24.1M | $20M | $26.6M | $30.5M | |
| EBITDA | -$5.7M | -$9.8M | -$12.6M | -$31.3M | -$39.5M | |
| EBIT | -$5.7M | -$9.8M | -$12.8M | -$31.7M | -$40M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$5.7M | -$9.8M | -$12.8M | -$31.7M | -$40M | |
| Operating Income (Adjusted) | -$5.7M | -$9.8M | -$12.8M | -$31.7M | -$40M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | $347K | |
| Gross Profit | -- | -- | -- | -- | -$347K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $1.2M | $8.7M | $6.8M | $10.3M | |
| Selling, General & Admin | -- | $1.4M | $2.2M | $2.9M | $12.7M | |
| Other Inc / (Exp) | -- | $137K | $27K | $1.1M | -- | |
| Operating Expenses | -- | $2.5M | $11M | $9.7M | $22.7M | |
| Operating Income | -- | -$2.5M | -$11M | -$9.7M | -$23M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$2.4M | -$10.9M | -$8.7M | -$21.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $1K | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$2.4M | -$10.9M | -$8.7M | -$21.7M | |
| Basic EPS (Cont. Ops) | -- | -$0.10 | -$0.40 | -$0.28 | -$0.65 | |
| Diluted EPS (Cont. Ops) | -- | -$0.10 | -$0.40 | -$0.28 | -$0.65 | |
| Weighted Average Basic Share | -- | $24.9M | $27.3M | $30.7M | $33.2M | |
| Weighted Average Diluted Share | -- | $24.9M | $27.3M | $30.7M | $33.2M | |
| EBITDA | -- | -$2.5M | -$11M | -$9.7M | -$22.7M | |
| EBIT | -- | -$2.5M | -$11M | -$9.7M | -$23M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$2.5M | -$11M | -$9.7M | -$23M | |
| Operating Income (Adjusted) | -- | -$2.5M | -$11M | -$9.7M | -$23M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | $347K | |
| Gross Profit | -- | -- | -- | -- | -$347K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $25.2M | $27.5M | $38M | |
| Selling, General & Admin | -- | -- | $4.7M | $7.9M | $29.6M | |
| Other Inc / (Exp) | -- | $235K | $11K | $2.4M | -- | |
| Operating Expenses | -- | -- | $31.4M | $35.5M | $67.2M | |
| Operating Income | -- | -- | -$31.4M | -$35.5M | -$67.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$24.6M | -$33M | -$62.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $10K | $6K | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$31.4M | -$33M | -$62.4M | |
| Basic EPS (Cont. Ops) | -- | -- | -$1.30 | -$1.11 | -$1.92 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.99 | -$1.11 | -$1.92 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -$31.2M | -$35.5M | -$67.2M | |
| EBIT | -- | -- | -$31.2M | -$35.5M | -$67.6M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$31.4M | -$35.5M | -$67.6M | |
| Operating Income (Adjusted) | -- | -- | -$31.2M | -$35.5M | -$67.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | $347K | |
| Gross Profit | -- | -- | -- | -- | -$347K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $3.6M | $20M | $22.7M | $30.8M | |
| Selling, General & Admin | -- | $2.5M | $4.7M | $5.9M | $25.4M | |
| Other Inc / (Exp) | -- | $235K | $81K | $2.5M | $2.5M | |
| Operating Expenses | -- | $6.1M | $24.7M | $28.5M | $55.8M | |
| Operating Income | -- | -$6.1M | -$24.7M | -$28.5M | -$56.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$5.9M | -$24.6M | -$26M | -$52.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $10K | $6K | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$5.9M | -$24.6M | -$26M | -$52.3M | |
| Basic EPS (Cont. Ops) | -- | -$0.26 | -$0.99 | -$0.86 | -$1.60 | |
| Diluted EPS (Cont. Ops) | -- | -$0.27 | -$0.99 | -$0.86 | -$1.60 | |
| Weighted Average Basic Share | -- | $68.6M | $74.1M | $90.7M | $97.9M | |
| Weighted Average Diluted Share | -- | $68.6M | $74.1M | $90.7M | $97.9M | |
| EBITDA | -- | -$6.1M | -$24.7M | -$28.5M | -$55.8M | |
| EBIT | -- | -$6.1M | -$24.7M | -$28.5M | -$56.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$6.1M | -$24.7M | -$28.5M | -$56.1M | |
| Operating Income (Adjusted) | -- | -$6.1M | -$24.7M | -$28.5M | -$56.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $25.6M | $17.3M | $42.1M | $88.2M | $145.1M | |
| Short Term Investments | -- | -- | -- | -- | $113.5M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $10K | $64K | $699K | $916K | $1.3M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $25.7M | $17.4M | $42.8M | $89.9M | $147.1M | |
| Property Plant And Equipment | $66K | $94K | $1.3M | $1.3M | $965K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | $31K | $3.3M | $4M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $25.7M | $18.3M | $44.3M | $94.6M | $152.1M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | $941K | $1.4M | $1.5M | $2.4M | $4.8M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $198K | $308K | $276K | |
| Other Current Liabilities | $5K | $95K | $74K | $149K | $289K | |
| Total Current Liabilities | $972K | $1.6M | $2.1M | $3.6M | $6.1M | |
| Long-Term Debt | $31.8M | $31.8M | $668K | $578K | $261K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $32.8M | $33.4M | $2.8M | $4.2M | $6.3M | |
| Common Stock | $1K | $1K | $3K | $3K | $3K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -$7M | -$15.1M | $41.5M | $90.4M | $145.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$7M | -$15.1M | $41.5M | $90.4M | $145.8M | |
| Total Liabilities and Equity | $25.7M | $18.3M | $44.3M | $94.6M | $152.1M | |
| Cash and Short Terms | $25.6M | $17.3M | $42.1M | $88.2M | $145.1M | |
| Total Debt | $31.8M | $31.8M | $668K | $578K | $261K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $54.5M | $109M | $275.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | $1.6M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | $56.1M | $111.3M | $277.2M | |
| Property Plant And Equipment | -- | -- | -- | -- | $826K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | $1.5M | $4.6M | -- | |
| Total Assets | -- | -- | $57.6M | $115.8M | $282.4M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $8.1M | |
| Long-Term Debt | -- | -- | -- | -- | $245K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $4.8M | $3.6M | $8.3M | |
| Common Stock | -- | -- | -- | -- | $3K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $52.8M | $112.2M | $274.1M | |
| Total Liabilities and Equity | -- | -- | $57.6M | $115.8M | $282.4M | |
| Cash and Short Terms | -- | -- | $54.5M | $109M | $275.6M | |
| Total Debt | -- | -- | -- | -- | $245K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$5.8M | -$9.7M | -$12.6M | -$31.6M | -$36.1M | |
| Depreciation & Amoritzation | $17K | $30K | $198K | $399K | $449K | |
| Stock-Based Compensation | $1.4M | $1.5M | $1.5M | $3.8M | $9M | |
| Change in Accounts Receivable | $4K | -- | -$32K | -$72K | $74K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$4.4M | -$7.5M | -$11.5M | -$29.8M | -$29.2M | |
| Capital Expenditures | $20K | $74K | $394K | $63K | $151K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$20K | -$56K | -$394K | -$63K | -$110.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $131K | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$2.5M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$815K | -$1M | -$1.2M | -$368K | |
| Cash From Financing | $28.1M | -$583K | $37M | $76M | $83.6M | |
| Beginning Cash (CF) | $25.6M | $17.3M | $42.1M | $88.2M | $31.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $23.6M | -$8.3M | $24.7M | $46.1M | -$56.5M | |
| Ending Cash (CF) | $49.2M | $8.9M | $66.5M | $134.2M | -$25.1M | |
| Levered Free Cash Flow | -$4.5M | -$7.5M | -$11.9M | -$29.9M | -$29.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | $54.5M | $109M | $157M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2022-01-18 | 2023-01-18 | 2024-01-18 | 2025-01-18 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | $149.7M | $316.8M | $463.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get BLTE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BLTE
Sector
P/E ratio
--
23.89x
PEG ratio
-1.10x
-0.01x
P/B ratio
21.23x
1.81x
Price / LTM sales
--
1.59x
Growth Metrics
BLTE
Sector
Revenue growth
--
4.35%
Earnings growth
-130.87%
9.8%
Revenue (5-year growth)
--
6.41%
Earnings forecast
-$0.63
-$0.18
Profitability
BLTE
Sector
Profitability FY 2024
-$449K
$3.2M
Return on invested capital
-37.09%
-32.76%
Return on assets
-35.82%
-29.32%
Return on equity
-37.13%
-38.6%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Mar
10
Estimated Next Earnings Date
Feb
9
Balance Sheet
BLTE
Sector
Total cash
$275.6M
$25.4M
Short term investments
$113.5M
$25.1M
Total assets
$152.1M
$74.7M
Long term debt
$245K
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
